by qfrsolutions | Oct 28, 2014 | News
Source: Gallup Management talent exists in every company. It’s often hiding in plain sight. Gallup has found that one of the most important decisions companies make is simply whom they name manager. Yet our analytics suggest they usually get it wrong. In fact,...
by qfrsolutions | Sep 19, 2014 | News
Source: FierceBiotech In victory for industry, FDA’s second attempt to classify Prevor’s skin wash as a device is vacated once again. The U.S. District Court for the District of Columbia rejected the FDA’s attempt to classify Prevor’s...
by qfrsolutions | Sep 4, 2014 | News
Source: FierceBiotech Hot on the heels of its $805 million development deal with Infinity, AbbVie Pharmaceuticals ($ABBV) has followed up today with a plan to partner with Google’s ($GOOG) closely watched biotech upstart Calico on a new research operation that...
by qfrsolutions | Aug 20, 2014 | News
Source: Margins, margins, margins. That’s an inevitable mantra among top investors and analysts. Just ask Novartis ($NVS) CEO Joe Jimenez, who’s pledged big improvements in the Swiss drugmaker’s spread. Or Eli Lilly ($LLY) CFO Derica Rice,...
by qfrsolutions | Aug 19, 2014 | News
Source: Bidness ETC Threats from the increase in drug-resistant germs, and the subsequent rise in demand for more effective and high-impact antibiotics has spurred interest in companies such as Cubist Pharmaceuticals Inc (CBST). The Massachusetts-based drug developer...
